期刊文献+

LDL/HDL比值与急性缺血性脑卒中危险因素的关系及预后价值 被引量:2

LDL/HDL ratio: its correlation to acute ischemic stroke risk factors and its implication for prognosis
下载PDF
导出
摘要 目的探讨低密度脂蛋白/高密度脂蛋白(LDL/HDL)比值与急性缺血性脑卒中患者危险因素的关系及对预后的预测价值。方法检测38例急性缺血性脑卒中住院患者(观察组)及同期体检人员44例(对照组)的血浆LDL、HDL水平,计算LDL/HDL比值并统计其一般资料和危险因素;对所有患者进行常规治疗,检测治疗前后LDL、HDL水平及比值,并进行1-2年的随访。结果观察组LDL/HDL明显高于对照组,治疗后显著降低,但仍明显高于对照组,差异具有统计学意义(均P〈0.05);Spearman分析显示急性缺血性脑卒中患者LDL/HDL比值与动脉硬化、心脏病、高血压、BMI危险因素及预后均呈正相关性(均P〈0.05)。结论 LDL/HDL比值是急性缺血性脑卒中的独立危险因素,与其预后明显正相关,可用于临床预测。 Objective To investigate the correlation of LDL / HDL ratio to the risk factors of acute ischemic stroke and its implication for prognosis. Method 38 patients of acute ischemic stroke were firstly chosen as the experimental group and 44 healthy people as determined by physical check-up were chosen as the control group of the study. The plasma LDL and HDL levels and the ratio before and after treatment were measured and calculated. Risk factors and prognosis were recorded and follow-ups were conducted for 1-2 years. Correlation between LDH / HDL ratio and risk factors / prognosis were analyzed. Findings Before treatment,the LDL / HDL ratio in the experimental group was significantly higher than that in control group and was reduced significantly after treatment( P〈0. 05),yet still higher than that in the control group( P〈0. 05). Correlation analysis showed that LDL / HDL ratio was positively correlated with other risk factors and prognosis( P〈0. 05). Conclusion LDL / HDL ratio can serve as an independent risk factor that triggers acute ischemic stroke. It has significantly positive correlation with the prognosis.
出处 《健康研究》 CAS 2016年第2期123-125,共3页 Health Research
关键词 LDL/HDL比值 急性缺血性脑卒中 预后 评估 LDL/HDL ratio acute ischemic stroke prognosis evaluation
  • 相关文献

参考文献8

二级参考文献32

  • 1李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1783
  • 2Wilson PW, High-density lipoprotein,low-density lipoprotein and coronary artery disease. Am J Cardiol, 1990,66: 7A-10A.
  • 3van de Woestijne AP,van der Graaf Y,Liem AH,et al. Low high-density lipoprotein choh.sterol is not a risk factor for re- current vascular events in patients with vascular disease on in tensive lipid-lowering medication. J Am Coil Cardiol, 2013,62:1834-1841.
  • 4Woodward M,Barzi F,Feigin V, et al. Associations between high-density lipoprotein cholesterol and both stroke and coro- nary heart disease in the Asia Pacific region. Eur Heart J, 2007,28 : 2653-2660.
  • 5Bots ML,Elwood PC,Nikitin Y,et al. Total and HI)l. choles- terol and risk of stroke. EUROSTRONE:a collaborative study among research centres in Europe. J Epidemiol Community Health ,2002,56 : 19-24.
  • 6Wang Y,Cui L,Ji X,et al. The China National Stroke Regis- try for patients with acute cerebrovascular events:design,ra- tionale, and baseline patient characteristics. Int J Stroke, 2011,6:355- 361.
  • 7Alsheikh-Ali AA, Lin JL, Abourjaily P, et al. Prevalence of low high-density lipoprotein cholesterol in patients with docu mented coronary high disease or risk equivalent and controlled low-density lipoprotein cholesterol. Am J Cardiol, 2007,100: 1499-1501.
  • 8Grover SA, Kaouache M, Joseph L, et al. Evaluating the incre- mental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels. Arch Intern Med, 2009,26:1775- 1780.
  • 9Riwanto MI, Landmesser U. High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease. J Lipid Res, 2018,54 : 3227-3243.
  • 10Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory prop- erties of HDL. Circ Res,2004,95 :764-772.

共引文献306

同被引文献14

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部